Reply to I.F. Tannock, P. Isaacsson Velho et al, M. Tiako Meyo et al, and F.J.S.H. Woei-A-Jin et al
- 20 October 2018
- journal article
- letter
- Published by American Society of Clinical Oncology (ASCO) in Journal of Clinical Oncology
- Vol. 36 (30), 3064-3065
- https://doi.org/10.1200/jco.2018.79.3190
Abstract
No abstract availableThis publication has 12 references indexed in Scilit:
- Low-Fat Abiraterone Food Effect Is of Great ConsequenceJournal of Clinical Oncology, 2018
- Low-Dose Abiraterone Regimen: Drug Monitoring Might Be the KeyJournal of Clinical Oncology, 2018
- Prospective International Randomized Phase II Study of Low-Dose Abiraterone With Food Versus Standard Dose Abiraterone In Castration-Resistant Prostate CancerJournal of Clinical Oncology, 2018
- Randomized phase 2 therapeutic equivalence study of abiraterone acetate fine particle formulation vs. originator abiraterone acetate in patients with metastatic castration-resistant prostate cancer: The STAAR studyUrologic Oncology: Seminars and Original Investigations, 2018
- High-Dose Abiraterone Acetate in Men With Castration Resistant Prostate CancerClinical Genitourinary Cancer, 2017
- Relation between plasma trough concentration of abiraterone and prostate-specific antigen response in metastatic castration-resistant prostate cancer patientsEuropean Journal of Cancer, 2016
- Population Pharmacokinetic Analysis of Abiraterone in Chemotherapy-Naïve and Docetaxel-Treated Patients with Metastatic Castration-Resistant Prostate CancerClinical Pharmacokinetics, 2014
- Evidence for Therapeutic Drug Monitoring of Targeted Anticancer TherapiesJournal of Clinical Oncology, 2012
- Phase I Clinical Trial of the CYP17 Inhibitor Abiraterone Acetate Demonstrating Clinical Activity in Patients With Castration-Resistant Prostate Cancer Who Received Prior Ketoconazole TherapyJournal of Clinical Oncology, 2010
- Phase I Clinical Trial of a Selective Inhibitor of CYP17, Abiraterone Acetate, Confirms That Castration-Resistant Prostate Cancer Commonly Remains Hormone DrivenJournal of Clinical Oncology, 2008